SR
Syntax Research’s C4 Therapeutics CCCC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.43K | Hold |
1,000
| – | – | ﹤0.01% | 168 |
|
2025
Q1 | $1.6K | Hold |
1,000
| – | – | ﹤0.01% | 173 |
|
2024
Q4 | $3.6K | Hold |
1,000
| – | – | ﹤0.01% | 172 |
|
2024
Q3 | $5.7K | Hold |
1,000
| – | – | ﹤0.01% | 165 |
|
2024
Q2 | $4.62K | Hold |
1,000
| – | – | ﹤0.01% | 158 |
|
2024
Q1 | $8.17K | Hold |
1,000
| – | – | 0.01% | 141 |
|
2023
Q4 | $5.65K | Hold |
1,000
| – | – | ﹤0.01% | 154 |
|
2023
Q3 | $1.86K | Buy |
+1,000
| New | +$1.86K | ﹤0.01% | 174 |
|